Royal Bank of Canada
BRLI

Royal Bank of Canada’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Royal Bank of Canada’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-619,330
Closed -$25.5M – 7022
2015
Q2 		$25.5M Sell
619,330
-1,098,928
-64% -$39.4M 0.02% 684
2015
Q1 		$60.6M Buy
1,718,258
+142,366
+9% +$4.82M 0.04% 327
2014
Q4 		$50.6M Buy
1,575,892
+199,175
+14% +$5.76M 0.03% 406
2014
Q3 		$38.6M Buy
1,376,717
+148,159
+12% +$4.51M 0.03% 470
2014
Q2 		$37.1M Buy
1,228,558
+148,428
+14% +$4.1M 0.03% 487
2014
Q1 		$29.9M Buy
1,080,130
+17,721
+2% +$464K 0.02% 540
2013
Q4 		$27.1M Buy
1,062,409
+120,664
+13% +$3.72M 0.02% 625
2013
Q3 		$28.1M Buy
941,745
+196,929
+26% +$5.48M 0.02% 558
2013
Q2 		$21.4M Buy
+744,816
New +$20.5M 0.02% 620

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Royal Bank of Canada's BRLI Position: Q3 2015 in Review

Royal Bank of Canada sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 619,330 shares — an estimated $25.5M sold.

Royal Bank of Canada first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $60.6M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Royal Bank of Canada reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 619,330 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $25.5M.
  • Royal Bank of Canada first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Royal Bank of Canada's BIO-REFERENCE LABS INC-NEW- position peaked at $60.6M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Royal Bank of Canada's 13F filing for Q3 2015, filed 16 Nov 2015.